IBP Stock +106.23% Since Nov ’07 Pick IBP Stock +106.23% Since Nov ’07 Pick Unlock Top Buy Picks

Range Low Price High Price Comment
30 days $197.79 $229.90 Friday, 12th Apr 2024 BIIB stock ended at $198.18. This is 2.70% less than the trading day before Thursday, 11th Apr 2024. During the day the stock fluctuated 3.77% from a day low at $197.79 to a day high of $205.24.
90 days $197.79 $252.17
52 weeks $197.79 $319.76

Historical Biogen Inc. prices
JSON

CSV

Date Open High Low Close Volume
2024-04-12 $204.23 $205.24 $197.79 $198.18 1 223 199
2024-04-11 $202.76 $204.74 $200.97 $203.68 1 017 431
2024-04-10 $203.00 $203.99 $200.65 $201.55 872 232
2024-04-09 $205.02 $209.06 $205.02 $206.52 961 313
2024-04-08 $203.89 $205.77 $202.91 $204.95 723 651
2024-04-05 $204.28 $205.19 $202.18 $203.87 922 972
2024-04-04 $207.24 $210.00 $205.22 $205.30 758 607
2024-04-03 $207.71 $208.70 $205.36 $206.38 870 310
2024-04-02 $213.09 $213.37 $207.58 $207.64 1 461 772
2024-04-01 $215.69 $215.69 $212.56 $214.83 823 955
2024-03-28 $217.36 $217.57 $214.00 $215.63 1 760 515
2024-03-27 $213.75 $216.34 $212.95 $216.34 1 241 426
2024-03-26 $216.15 $216.67 $211.02 $212.02 1 589 049
2024-03-25 $217.77 $218.26 $215.59 $216.69 679 177
2024-03-22 $221.30 $221.30 $215.36 $218.10 1 046 831
2024-03-21 $219.33 $221.74 $217.95 $220.75 994 897
2024-03-20 $217.18 $219.36 $216.53 $218.15 808 061
2024-03-19 $218.35 $219.02 $215.59 $218.63 1 501 773
2024-03-18 $220.34 $220.56 $217.64 $219.40 1 338 161
2024-03-15 $219.15 $221.31 $216.80 $219.31 2 402 070
2024-03-14 $225.25 $225.25 $218.58 $219.62 1 565 821
2024-03-13 $228.76 $229.90 $224.93 $226.56 1 463 762
2024-03-12 $229.34 $229.75 $225.35 $227.36 1 056 419
2024-03-11 $223.30 $230.22 $223.24 $230.07 1 197 857
2024-03-08 $225.45 $228.21 $221.98 $223.24 1 606 385
Click to get the best stock tips daily for free!

About Biogen Inc.

Biogen. Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; ADUHELM for the treatment of Alzheimer's disease; IMRALDI, an ad... BIIB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT